Open Access

QUANTITATIVE EVALUATION OF ARTIFICIAL INTELLIGENCE IN HOSPITAL MANAGEMENT: SYSTEMATIC REVIEW OF REAL-WORLD IMPLEMENTATIONS AND OUTCOMES (2019–2024)

4 Doctoral School of the University of Burundi, Center for Research in Infrastructure, Environment and Technology (CRIET), Burundi
4 Department of Information and Communication Technologies, Higher Institute of Applied Sciences, University of Burundi, Burundi
4 Institute of Digital Technologies, University of Burundi, Burundi
4 EPAC, Ecole Polytechnique d’Abomey-Calavi; Université d’Abomey-Calavi, Cotonou-Bénin

Abstract

Hospitals around the world are under growing pressure due to limited resources, shifting demographics, and rising demands for quality care. Artificial intelligence (AI) has emerged as a promising ally to help address these challenges, yet real-world evidence about its implementation and impact remains scattered. This study, conducted following PRISMA 2020 guidelines, reviewed 52 empirical investigations published between 2019 and 2024 that reported quantitative outcomes of AI applications in hospital management. Our findings show that AI adoption rose from 66% in 2023 to 71% in 2024, although sharp disparities persist between university hospitals (87%) and rural facilities (41%). Meta-analyses revealed significant benefits: administrative efficiency improved by 30–45%, diagnostic accuracy by 12–18%, hospital stays shortened by 1.2–2.1 days, and resource allocation costs dropped by 15–25%. Despite initial investments ranging from $430,000 to $6.2 million, the average return on investment reached 267% within three years. However, implementation remains challenging—77% of projects faced technical integration issues, 71% reported inadequate staff training, and 56% struggled with regulatory compliance. Overall, while AI brings measurable and meaningful gains to hospital management, its success depends as much on human and organizational readiness as on technological capability. Bridging the equity gap between well-resourced and under-resourced institutions should be a policy priority, and future research must focus on long-term sustainability, standardized evaluation frameworks, and strategies adapted to resource-limited settings.

Keywords

References

📄 W. H. Organization, Advancing the responsible use of digital technologies in global health: A report of the WHO Science Council. World Health Organization, 2025. Accessed: Nov. 10, 2025. [Online]. Available: https://books.google.com/books?hl=fr&lr=&id=q8-KEQAAQBAJ&oi=fnd&pg=PR4&dq=World+Health+Organization.+Global+Strategy+on+Digital+Health+2020-2025.+Geneva:+WHO%3B+2021.&ots=g8UorjXWnv&sig=NbVnJ542KZozt7nTlJbPQYBiMgQ
📄 J. M. McGinnis, L. Stuckhardt, R. Saunders, and M. Smith, ‘Best care at lower cost: the path to continuously learning health care in America’, 2013, Accessed: Nov. 10, 2025. [Online]. Available: https://books.google.com/books?hl=fr&lr=&id=_wUw6XCFqGwC&oi=fnd&pg=PR1&dq=1.%09Institute+of+Medicine.+Best+Care+at+Lower+Cost:+The+Path+to+Continuously+Learning+Health+Care+in+America.+Washington,+DC:+National+Academies+Press%3B+2012.&ots=0Mozxbgizp&sig=gx1WuLBL0WBBaFG9Vt-cHLbJsGM
📄 S. Scarpetta and C. di Noia, ‘Pensions at a Glance 2023: OECD AND G20 INDICATORS.’, Pensions at a Glance, 2023, Accessed: Nov. 10, 2025. [Online]. Available: https://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=19954026&asa=N&AN=177979553&h=dWHlZgac6mWk6AMKQ7uf0WGUQbU9w8uaC45C7vdF00kmpd8BZgGmgn9sfYMEO60nzD26flXjtAcz3f40YGv6cw%3D%3D&crl=f
📄 E. J. Topol, ‘High-performance medicine: the convergence of human and artificial intelligence’, Nature medicine, vol. 25, no. 1, pp. 44–56, 2019.
📄 K.-H. Yu, A. L. Beam, and I. S. Kohane, ‘Artificial intelligence in healthcare’, Nature biomedical engineering, vol. 2, no. 10, pp. 719–731, 2018.
📄 Esteva et al., ‘A guide to deep learning in healthcare’, Nature medicine, vol. 25, no. 1, pp. 24–29, 2019.
📄 T. Davenport and R. Kalakota, ‘The potential for artificial intelligence in healthcare’, Future healthcare journal, vol. 6, no. 2, pp. 94–98, 2019.
📄 Rajkomar, J. Dean, and I. Kohane, ‘Machine Learning in Medicine’, N Engl J Med, vol. 380, no. 14, pp. 1347–1358, Apr. 2019, doi: 10.1056/NEJMra1814259.
📄 F. Jiang et al., ‘Artificial intelligence in healthcare: past, present and future’, Stroke and vascular neurology, vol. 2, no. 4, 2017, Accessed: Nov. 10, 2025. [Online]. Available: https://svn.bmj.com/Content/2/4/230.abstract
📄 R. Vaishya, M. Javaid, I. H. Khan, and A. Haleem, ‘Artificial Intelligence (AI) applications for COVID-19 pandemic’, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 14, no. 4, pp. 337–339, 2020.
📄 J. Bullock, A. Luccioni, K. H. Pham, C. S. N. Lam, and M. Luengo-Oroz, ‘Mapping the landscape of artificial intelligence applications against COVID-19’, Journal of Artificial Intelligence Research, vol. 69, pp. 807–845, 2020.
📄 S. Lalmuanawma, J. Hussain, and L. Chhakchhuak, ‘Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review’, Chaos, Solitons & Fractals, vol. 139, p. 110059, 2020.
📄 B. McCall, ‘COVID-19 and artificial intelligence: protecting health-care workers and curbing the spread’, The Lancet Digital Health, vol. 2, no. 4, pp. e166–e167, 2020.
📄 R. M. Wehbe et al., ‘DeepCOVID-XR: An Artificial Intelligence Algorithm to Detect COVID-19 on Chest Radiographs Trained and Tested on a Large U.S. Clinical Data Set’, Radiology, vol. 299, no. 1, pp. E167–E176, Apr. 2021, doi: 10.1148/radiol.2020203511.
📄 W. Naudé, ‘Artificial intelligence vs COVID-19: limitations, constraints and pitfalls’, AI & Soc, vol. 35, no. 3, pp. 761–765, Sep. 2020, doi: 10.1007/s00146-020-00978-0.
📄 S. Reddy, S. Allan, S. Coghlan, and P. Cooper, ‘A governance model for the application of AI in health care’, Journal of the American medical informatics association, vol. 27, no. 3, pp. 491–497, 2020.
📄 C. J. Kelly, A. Karthikesalingam, M. Suleyman, G. Corrado, and D. King, ‘Key challenges for delivering clinical impact with artificial intelligence’, BMC Med, vol. 17, no. 1, p. 195, Dec. 2019, doi: 10.1186/s12916-019-1426-2.
📄 J. S. Roppelt, D. K. Kanbach, and S. Kraus, ‘Artificial intelligence in healthcare institutions: A systematic literature review on influencing factors’, Technology in society, vol. 76, p. 102443, 2024.
📄 Kamel Rahimi et al., ‘Implementing AI in hospitals to achieve a learning health system: systematic review of current enablers and barriers’, Journal of medical Internet research, vol. 26, p. e49655, 2024.
📄 S. V. Bhagat and D. Kanyal, ‘Navigating the future: the transformative impact of artificial intelligence on hospital management-a comprehensive review’, Cureus, vol. 16, no. 2, 2024, Accessed: Nov. 10, 2025. [Online]. Available: https://www.cureus.com/articles/219582-navigating-the-future-the-transformative-impact-of-artificial-intelligence-on-hospital-management--a-comprehensive-review.pdf
📄 D. A. Hashimoto, G. Rosman, D. Rus, and O. R. Meireles, ‘Artificial intelligence in surgery: promises and perils’, Annals of surgery, vol. 268, no. 1, pp. 70–76, 2018.
📄 X. Liu et al., ‘Correction to Lancet Digital Health 2019; 1: e271–97 (The Lancet Digital Health (2019) 1 (6)(e271–e297),(S2589750019301232),(10.1016/S2589-7500 (19) 30123-2))’, The Lancet Digital Health, vol. 1, no. 7, pp. e334–e334, 2019.
📄 M. Nagendran et al., ‘Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies’, bmj, vol. 368, 2020, Accessed: Nov. 10, 2025. [Online]. Available: https://www.bmj.com/content/368/bmj.m689.abstract
📄 H. Ibrahim, X. Liu, N. Zariffa, A. D. Morris, and A. K. Denniston, ‘Health data poverty: an assailable barrier to equitable digital health care’, The Lancet Digital Health, vol. 3, no. 4, pp. e260–e265, 2021.
📄 D. S. Char, N. H. Shah, and D. Magnus, ‘Implementing machine learning in health care—addressing ethical challenges’, The New England journal of medicine, vol. 378, no. 11, p. 981, 2018.
📄 R. B. Parikh, S. Teeple, and A. S. Navathe, ‘Addressing bias in artificial intelligence in health care’, Jama, vol. 322, no. 24, pp. 2377–2378, 2019.
📄 M. J. Page et al., ‘The PRISMA 2020 statement: an updated guideline for reporting systematic reviews’, bmj, vol. 372, 2021, Accessed: Nov. 10, 2025. [Online]. Available: https://www.bmj.com/content/372/bmj.n71.short
📄 J. A. Sterne et al., ‘RoB 2: a revised tool for assessing risk of bias in randomised trials’, bmj, vol. 366, 2019, Accessed: Nov. 10, 2025. [Online]. Available: https://www.bmj.com/content/366/bmj.l4898.short
📄 J. A. Sterne et al., ‘ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions’, bmj, vol. 355, 2016, Accessed: Nov. 10, 2025. [Online]. Available: https://www.bmj.com/CONTENT/355/BMJ.I4919.abstract
📄 G. A. Wells et al., ‘The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses’, 2000, Accessed: Nov. 10, 2025. [Online]. Available: https://scholar.archive.org/work/zuw33wskgzf4bceqgi7opslsre/access/wayback/www3.med.unipmn.it/dispense_ebm/2009-2010/Corso%20Perfezionamento%20EBM_Faggiano/NOS_oxford.pdf
📄 M. Campbell et al., ‘Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline’, bmj, vol. 368, 2020, Accessed: Nov. 10, 2025. [Online]. Available: https://www.bmj.com/content/368/bmj.l6890.abstract
📄 R. M. (RevMan)[Computer program, ‘Version 5.4, The Cochrane Collaboration’. The Cochrane Collaboration Copenhagen: The Nordic Cochrane Centre, 2020.
📄 R. M. Wachter and E. Brynjolfsson, ‘Will generative artificial intelligence deliver on its promise in health care?’, Jama, vol. 331, no. 1, pp. 65–69, 2024.
📄 M. P. Sendak, M. Gao, N. Brajer, and S. Balu, ‘Presenting machine learning model information to clinical end users with model facts labels’, NPJ digital medicine, vol. 3, no. 1, p. 41, 2020.
📄 E. Wu, K. Wu, R. Daneshjou, D. Ouyang, D. E. Ho, and J. Zou, ‘How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals’, Nature Medicine, vol. 27, no. 4, pp. 582–584, 2021.
📄 S. Benjamens, P. Dhunnoo, and B. Meskó, ‘The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database’, NPJ digital medicine, vol. 3, no. 1, p. 118, 2020.
📄 E. J. Topol, ‘Welcoming new guidelines for AI clinical research’, Nature medicine, vol. 26, no. 9, pp. 1318–1320, 2020.
📄 J. Guo and B. Li, ‘The Application of Medical Artificial Intelligence Technology in Rural Areas of Developing Countries’, Health Equity, vol. 2, no. 1, pp. 174–181, Aug. 2018, doi: 10.1089/heq.2018.0037.
📄 M. E. Matheny, D. Whicher, and S. T. Israni, ‘Artificial intelligence in health care: a report from the National Academy of Medicine’, Jama, vol. 323, no. 6, pp. 509–510, 2020.
📄 R. Hillestad et al., ‘Can Electronic Medical Record Systems Transform Health Care? Potential Health Benefits, Savings, And Costs’, Health Affairs, vol. 24, no. 5, pp. 1103–1117, Sep. 2005, doi: 10.1377/hlthaff.24.5.1103.
📄 J. Walker, E. Pan, D. Johnston, J. Adler-Milstein, D. W. Bates, and B. Middleton, ‘The Value Of Health Care Information Exchange And Interoperability: There is a business case to be made for spending money on a fully standardized nationwide system.’, Health Affairs, vol. 24, no. Suppl1, pp. W5-10-W5-18, Jan. 2005, doi: 10.1377/hlthaff.W5.10.
📄 M. Hassan, A. Kushniruk, and E. Borycki, ‘Barriers to and facilitators of artificial intelligence adoption in health care: scoping review’, JMIR Human Factors, vol. 11, p. e48633, 2024.
📄 M. I. Ahmed, B. Spooner, J. Isherwood, M. Lane, E. Orrock, and A. Dennison, ‘A systematic review of the barriers to the implementation of artificial intelligence in healthcare’, Cureus, vol. 15, no. 10, 2023, Accessed: Nov. 11, 2025. [Online]. Available: https://www.cureus.com/articles/170025-a-systematic-review-of-the-barriers-to-the-implementation-of-artificial-intelligence-in-healthcare.pdf

Similar Articles

11-20 of 28

You may also start an advanced similarity search for this article.